Skip to main content

Biomaterials Market Worth USD 245.6 Billion at 12.2% CAGR; Increasing Number of Novel Product Launches to Skyrocket Demand: Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, Aug. 27, 2020 (GLOBE NEWSWIRE) — The report mentions that the biomaterials market size was USD 110.0 billion in 2019 and is projected to reach USD 245.6 billion by 2027, thereby exhibiting a CAGR of 12.2% during the forecast period from 2020–2027. The global biomaterials market is set to gain impetus from the increasing usage of a wide variety of biomaterials because of their clinical efficiencies. They also provide several benefits in wound healing applications.This Report Answers the Following Questions:What are the latest trends in the market?How will the market be affected in the coming years?Which strategies are being adopted by key companies to aid growth?What are the market growth drivers and hindrances?
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/biomaterials-market-102770
Competitive Landscape-Key Players Aim to Gain Competitive Edge by Acquiring Other CompaniesThe market houses a large number of enterprises that are presently focusing on the strategies of acquisitions and achieving fast track approvals from the regulatory bodies for new biomaterials. Below are a couple of the latest key industry developments:November 2019: DiFusion, a biotechnology company based in Texas, bagged the 510K clearance from the USFDA. It was meant for the company’s Xiphos-ZF spinal interbody device. The device is created from ZFUZE, a new biomaterial that has proven to reduce Interleukin 6 and Interleukin 1-Beta significantly. It has also exhibited M2 macrophage response.December 2019: Advanced Medical Solutions (AMS), developer and manufacturer of technologically advanced and unique products for advanced wound care and surgical markets, successfully acquired Biomatlante, a surgical biomaterial technologies company. The total deal is worth €8 million. This new acquisition would aid AMS in strengthening its market access, R&D pipeline, and portfolio.The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this market.Please visit: https://www.fortunebusinessinsights.com/biomaterials-market-102770
Drivers & Restraints-Rising Usage of Natural & Synthetic Biomaterials for Cardiac Repair to Aid GrowthCardiovascular diseases are considered to be one of the major causes of death worldwide. Even though there are multiple pharmacological and surgical interventions that can be applied to enhance the quality of life of the patients affected by such diseases, less-invasive and cost-effective procedures are always more preferable.Both synthetic and natural biomaterials showcase high potential in cardiac regeneration and repair. Nowadays injectable biomaterials are used the most as they preserve cardiac functions, increase angiogenesis, and reduce left ventricular dilatation.However, there are numerous strict regulatory and clinical processes that the biomaterial-based devices have to go through to ensure their quality and efficacy. It may hamper the implantable biomaterials market growth.
Quick Buy –  Biomaterials Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102770
Regional Analysis-North America to Dominate Owing to High Government Funding in Development ActivitiesBased on geography, the market is segregated into the Middle East & Africa, Asia Pacific, North America, Latin America, and Europe. Out of these, North America is set to dominate the market. It had procured USD 44.83 billion revenue in 2019.This growth is attributable to the increasing funding by the governments of various countries in this region in development activities. Apart from this, the rising number of new product launches by industry giants, as well as higher incidence orthopedic replacements and cardiovascular diseases would contribute to the growth of the market in this region. Europe is anticipated to remain in the second position fueled by the emergence of innovative products in this region.Fortune Business Insights™ lists out all the companies operating in the global market. They are as follows:Invibio Ltd (Washington)Wright Medical Technology, Inc. (United States)Evonik Industries AG (Germany)Zimmer Biomet (United States)DePuy Synthes Companies (United States)DSM Biomedical, Inc. (Netherlands)Corbion NV (Netherlands)Other Players
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/biomaterials-market-102770
Biomaterials Market Segmentations:By Material●             Metallic●             Ceramic●             Polymers●             NaturalBy Application●             Cardiovascular●             Dental●             Orthopedic●             Plastic Surgery●             Urology●             Gastroenterology●             OthersBy Geography●             North America (the U.S. and Canada)●             Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)●             Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)●             Latin America (Brazil, Mexico, and the Rest of Latin America)●             Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/biomaterials-market-102770
Have a Look at Related Reports:Cardiovascular Devices Market Share and Industry Analysis, By Device Type (Diagnostic and Monitoring Devices, and Therapeutic and Surgical Devices), By Application (Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure, and Others), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2019-2026Plasma Fractionation Market Share & Industry Analysis, By Product Type (Albumin, Immunoglobulin (Intravenous Immunoglobulin and Subcutaneous Immunoglobulin), Coagulation Factors, Protease Inhibitors and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology and Others), By End User (Hospitals & Clinics,) and Geography Forecast, 2019-2026Orthopedic Implants Market Share & Industry Analysis, By Product (Joint Reconstruction; Spinal Implants; Trauma Implants, Dental Implants; Orthobiologics, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026Dental Implants Market Share and Global Trend By Material(Titanium Implants, Zirconium Implants), By Type(Endosteal Implants, Subperiosteal Implants, Transosteal Implants), By Design(Tapered Implants, Parallel Implants), By End-user(Hospitals, Dental Clinics, Academic & Research Institutes) and Geography Forecast till 2026Ultrasound Equipment Market Share and Global Trend By Type (Cart-based, Compact / Point-of-Care, Hand-held), By Application(Radiology, Cardiology, Gynecology), By End User(Hospitals, Clinics, Diagnostic Centers) and Geography Forecast till 2026Diabetes Monitoring Devices Market Share and Global Trend by Product (Blood Glucose Meters, Test Strips, Lancets), Distribution Channel (Institutional Sales, Retail Sales) & Geography Forecast till 2026
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/biomaterials-market-9906

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.